+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nerve Repair and Regeneration Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 510 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805293

Quick Summary:

The Nerve Repair and Regeneration Devices market is set to reach a stunning US$17.6 Billion by 2030, showcasing a pressing need to stay abreast of emerging trends, competitor strategies, and the ever-evolving business landscape. This report aims to equip savvy senior executives with robust and comprehensive market insights, enabling them to drive their organization's strategies with confidence and precision.

Showcasing an ecosystem of leading competitors such as Abbott Laboratories and Medtronic plc, the report offers exclusive insights into their tactics and market shares. Distilling complex market dynamics into actionable intelligence, it provides invaluable perspectives on major markets such as the U.S. and China. Access to digital archives and Research Platform, with the inclusion of complimentary updates for one year, ensures you remain knowledgeable on this cutting-edge market, empowering you with the foresight needed to lead in an increasingly competitive business environment.

Global Nerve Repair and Regeneration Devices Market to Reach $17.6 Billion by 2030

The global market for Nerve Repair and Regeneration Devices estimated at US$7.9 Billion in the year 2022, is projected to reach a revised size of US$17.6 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2022-2030. Neurostimulation & Neuromodulation Devices, one of the segments analyzed in the report, is projected to record 10.3% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Biomaterials segment is estimated at 12.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 13.6% CAGR

The Nerve Repair and Regeneration Devices market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.2% and 9.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 61 Featured)

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Collagen Matrix, Inc.
  • ERBE Elektromedizin GmbH
  • Inspire Medical Systems, Inc.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • Inomed Medizintechnik GmbH
  • Bioness Inc.
  • EMS Handels Gesellschaft mbH
  • Axonics Modulation Technologies, Inc.
  • Checkpoint Surgical Inc
  • BioArctic AB
  • Bovie Medical Corporation
  • Gimer Medical

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Nerve Repair and Regeneration Devices Market

What is the estimated value of the Nerve Repair and Regeneration Devices Market?

The Nerve Repair and Regeneration Devices Market was estimated to be valued at $7.9 Billion in 2022.

What is the growth rate of the Nerve Repair and Regeneration Devices Market?

The growth rate of the Nerve Repair and Regeneration Devices Market is 10.5%, with an estimated value of $17.6 Billion by 2030.

What is the forecasted size of the Nerve Repair and Regeneration Devices Market?

The Nerve Repair and Regeneration Devices Market is estimated to be worth $17.6 Billion by 2030.

Who are the key companies in the Nerve Repair and Regeneration Devices Market?

Key companies in the Nerve Repair and Regeneration Devices Market include Abbott Laboratories, Inc., Boston Scientific Corporation, Collagen Matrix, Inc., ERBE Elektromedizin GmbH, Inspire Medical Systems, Inc., Aleva Neurotherapeutics SA, Biowave Corporation, Inomed Medizintechnik GmbH, Bioness Inc. and EMS Handels Gesellschaft mbH.

Table of Contents

I. METHODOLOGY
II. EXECUTIVE SUMMARY
  • 1. GLOBAL MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
  • Global Nerve Repair & Regeneration Market Buckles under COVID-19 Strain
  • Covid-19 Patients in Prone Position Suffering Nerve Damage Bodes Well for Market Growth
  • Nerve Repair and Regeneration Market Set for a Robust Growth
  • Neurostimulation & Neuromodulation Devices Hold Commanding Slot in Nerve Repair & Regeneration Market
  • Biomaterials to Exhibit Rapid Growth
  • Nerve Repair and Regeneration Market by Application
  • US and Europe Dominate the Market
  • Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • High Incidence of Neurological Disorders: A Key Market Driver
  • Annual Incidence of Adult-Onset Neurologic Disorders in the US
  • Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
  • Increasing Cases of Peripheral Nerve Injuries Drive the Nerve Repair and Regeneration Market
  • Growing Number of Vehicular Accidents Drive the Peripheral Nerve injuries Repair Market
  • Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
  • Global Alzheimer's Prevalence by Age Group
  • Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
  • Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
  • Select Available Deep Brain Stimulation Devices Available in the Market
  • Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
  • Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
  • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
  • Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
  • Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
  • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
  • Recent Developments in Spinal Cord Injury Treatment
  • Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid Growth
  • New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies
  • Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
  • Innovative Nerve Conduits from Stryker
  • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
  • Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
  • Nerve Grafts for Bridging Larger Nerve Gaps
  • Role of Nerve Grafting in Treatment of Peripheral Nerve Injuries
  • FDA-approved Nerve Tubes for Peripheral Nerve Repair
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Nerve Repair and Regeneration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Neurostimulation & Neuromodulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Biomaterials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Neurostimulation & Neuromodulation Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Neurorrhaphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Nerve Grafting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 21: World 16-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 24: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 27: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 28: World Nerve Repair and Regeneration Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
  • UNITED STATES
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • CANADA
  • JAPAN
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • CHINA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • EUROPE
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • FRANCE
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • GERMANY
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • ITALY
  • UNITED KINGDOM
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • AUSTRALIA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Collagen Matrix, Inc.
  • ERBE Elektromedizin GmbH
  • Inspire Medical Systems, Inc.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • Inomed Medizintechnik GmbH
  • Bioness Inc.
  • EMS Handels Gesellschaft mbH
  • Axonics Modulation Technologies, Inc.
  • Checkpoint Surgical Inc
  • BioArctic AB
  • Bovie Medical Corporation
  • Gimer Medical